Skip to content

Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery

The Effect of Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06790732
Enrollment
60
Registered
2025-01-24
Start date
2023-05-01
Completion date
2024-05-01
Last updated
2025-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PeriCapsular Nerve Group Block, Postoperative Analgesia, Preoperative, Shoulder Arthroscopic Surgery, Ultrasound-Guided

Brief summary

This study aimed to evaluate the analgesic efficacy of preoperative ultrasound-guided peri-capsular nerve group block (PENG) on postoperative analgesia after shoulder arthroscopic surgery.

Detailed description

Postoperative pain control after shoulder surgery is challenging, and poor pain management is invariably reflected in poor outcomes, with longer hospitalization and recovery time. The difficulty in reducing pain due to the complexity of shoulder innervation leads to conducting studies to explore selective axillary nerve blocks with a posterior approach or from the axillae. The peri-capsular nerve group (PENG) block is a regional anesthetic technique. It can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. It targets only the sensory branches and not the posterior mechanoreceptors; there is a potential motor-sparing effect which is desirable for better physical therapy, and earlier discharge.

Interventions

DRUGSaline

Patients received sham PENG block (just 1mL saline).

Patients received real PENG block (15 mL of bupivacaine 0.25% +0.2mg/mL dexamethasone).

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age from 21 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-III. * Scheduled for unilateral shoulder arthroscopic surgery.

Exclusion criteria

* Patient refusal. * Known hypersensitivity to local anesthetics. * Body mass index\> 35 kg /m2. * Uncooperative or psychiatric patients. * Infection at the injection site. * Coagulation disorder. * Major cardiac, renal, or hepatic diseases.

Design outcomes

Primary

MeasureTime frameDescription
Time to the first request of rescue analgesia24 hours postoperativelyTime to the first request of rescue analgesia was recorded from the end of the surgery till first dose of morphine administrated.

Secondary

MeasureTime frameDescription
Degree of pain24 hours postoperativelyThe degree of pain was assessed using the Numerical Rating Scale (NRS) Pain score (metric score from 0 to 10 where 0 = no pain and 10 = maximal pain). NRS was recorded at PACU and 2, 4, 6, 8, 12, 16, 20, and 24 h postoperative.
Total morphine consumption24 hours postoperativelyIf patient numeric rating score was more than 3, patients received 3 mg morphine slowly intravenously. Morphine injection was repeated whenever required.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026